Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
Clinical trial NCT04282954 · COMPLETED
Trial details
- NCT number
- NCT04282954
- Sponsor
- Onconic Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-15
- Primary completion
- 2020-10-20
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.